2012
DOI: 10.1371/journal.pcbi.1002473
|View full text |Cite
|
Sign up to set email alerts
|

Ligand-Dependent Conformations and Dynamics of the Serotonin 5-HT2A Receptor Determine Its Activation and Membrane-Driven Oligomerization Properties

Abstract: From computational simulations of a serotonin 2A receptor (5-HT2AR) model complexed with pharmacologically and structurally diverse ligands we identify different conformational states and dynamics adopted by the receptor bound to the full agonist 5-HT, the partial agonist LSD, and the inverse agonist Ketanserin. The results from the unbiased all-atom molecular dynamics (MD) simulations show that the three ligands affect differently the known GPCR activation elements including the toggle switch at W6.48, the ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
129
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 100 publications
(136 citation statements)
references
References 115 publications
(209 reference statements)
7
129
0
Order By: Relevance
“…Thus, the interaction of the (1)-6-OH-7-Cl-PAT 6-OH moiety with S5.46 was crucial for its binding, whereas this amino acid hardly impacted binding of (2)-6-OH-7-Cl-PAT. This observation is unusual compared with most other 5-HT2A-targeting compounds reported (Almaula et al, 1996a;Braden and Nichols, 2007;Shan et al, 2012), including DOI. For example, of more than 20 compounds tested, only the ergot derivatives, e.g., ergonovine, showed major losses in affinity at the human S5.46A 5-HT2A receptor (Almaula et al, 1996a;Braden and Nichols, 2007).…”
Section: Discussionmentioning
confidence: 63%
“…Thus, the interaction of the (1)-6-OH-7-Cl-PAT 6-OH moiety with S5.46 was crucial for its binding, whereas this amino acid hardly impacted binding of (2)-6-OH-7-Cl-PAT. This observation is unusual compared with most other 5-HT2A-targeting compounds reported (Almaula et al, 1996a;Braden and Nichols, 2007;Shan et al, 2012), including DOI. For example, of more than 20 compounds tested, only the ergot derivatives, e.g., ergonovine, showed major losses in affinity at the human S5.46A 5-HT2A receptor (Almaula et al, 1996a;Braden and Nichols, 2007).…”
Section: Discussionmentioning
confidence: 63%
“…In earlier computational studies, ligand-dependent dynamics of GPCRs were investigated using the cMD (7,10), metadynamics (8,9), and aMD (11) methods. Whereas cMD simulations revealed distinct conformational changes in several known GPCR activation elements (7), these simulations lasting several hundred nanoseconds were not long enough to capture the entire GPCR activation/ deactivation processes.…”
Section: Discussionmentioning
confidence: 99%
“…The structure, dynamics, and function of GPCRs result from underlying free energy landscapes (4). However, quantitative characterization of the GPCR activation and ligand-dependent free energy profiles has proved challenging (4)(5)(6)(7)(8)(9)(10)(11)(12).…”
mentioning
confidence: 99%
“…Although these crystal structures provided enormously important insights into different specific conformational states, as well as atomistic protein-ligand interactions of GPCRs, they nonetheless represent snapshots of the highly dynamic nature of GPCRs (20). To address the above issue, extensive computational simulations have been performed to characterize the structural dynamics of GPCRs (20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33). All-atom molecular dynamics (MD) simulations are capable of exploring large-scale conformational changes during both receptor activation (23) and deactivation (20) by using fast supercomputers.…”
Section: Significancementioning
confidence: 99%